Exponent (EXPO) reported fiscal Q2 earnings late Thursday of $0.60 per diluted share, up from $0.52 a year earlier.

Analysts polled by FactSet expected $0.55.

Revenue for the three months ended July 3 was $171.6 million, up from $142 million a year earlier.

Revenue before reimbursements for the quarter was $148.9 million, up from $132.9 million a year ago.

Three analysts expected $145 million.

For Q3, the company expects revenue before reimbursements growth of 8% to 10%.

For the full-year 2026, the company now expects revenue before reimbursements growth of 9% to 10%.